Article
Glycaemic and bodyweight effects of <i>GIPR</i> coding variation reflect differences in both surface expression and intrinsic functional impairment
2025-08-19
Abstract excerpt
The glucose-dependent insulinotropic polypeptide receptor (GIPR) is the target of several approved and investigational drugs for type 2 diabetes and obesity. Missense coding variation in GIPR could confer phenotypic effects through altered constitutive or functional responses to GIP or alter the efficacy of pharmacological agents targeting this receptor. We aimed to provide a deep understanding of the cellular and...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e5120832-2603-536c-8994-b59aa1788585
- DOI
- 10.1101/2025.08.15.25333807
